Reza Bahadori
Corporate Officer/Principal presso The National Investment Banking Association
Posizioni attive di Reza Bahadori
Società | Posizione | Inizio | Fine |
---|---|---|---|
The National Investment Banking Association | Corporate Officer/Principal | - | - |
Storia della carriera di Reza Bahadori
Precedenti posizioni note di Reza Bahadori
Società | Posizione | Inizio | Fine |
---|---|---|---|
Chemokine Therapeutics Corp.
Chemokine Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Chemokine Therapeutics Corp. is a biotechnology company, developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases. The company's product candidates in clinical trials include CTCE-0214, for enhancing the immune system; and CTCE-9908, to prevent the spread of cancer and its continued growth. Chemokine Therapeutics was founded on July 15, 1998 and is headquartered in Vancouver, Canada. | Direttore/Membro del Consiglio | 14/12/2007 | 18/07/2008 |
Statistiche
Distribuzione geografica
Canada | 2 |
Stati Uniti | 2 |
Posizioni
Director/Board Member | 1 |
Corporate Officer/Principal | 1 |
Settori
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Chemokine Therapeutics Corp.
Chemokine Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Chemokine Therapeutics Corp. is a biotechnology company, developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases. The company's product candidates in clinical trials include CTCE-0214, for enhancing the immune system; and CTCE-9908, to prevent the spread of cancer and its continued growth. Chemokine Therapeutics was founded on July 15, 1998 and is headquartered in Vancouver, Canada. | Health Technology |
The National Investment Banking Association |
- Borsa valori
- Insiders
- Reza Bahadori
- Esperienza